The agency is proposing a requirement that companies submit data when self-affirming an additive is safe for consumption.

The Food and Drug Administration is taking a closer look at reports of deaths among young people and pregnant women following COVID-19 vaccinations—an inquiry that comes despite years of global ...

G. Caleb Alexander has chaired or served on more than a dozen FDA advisory committees. He’s worried the shift to ‘expert’ ...

The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...

The crackdown comes as the FDA has scaled back enforcement in recent decades. The agency once sent more than 100 warning ...

The U.S. Food and Drug Administration is tightening oversight of imports of GLP-1 drug ingredients, used for weight loss and ...

The US FDA has issued new guidance on ways to expand development of non-opioid treatment options for chronic pain.

This reform aims to enhance transparency in an industry where advertising has been linked to increased prescription drug use ...

The FDA has issued new draft guidance to promote safe and effective non-opioid treatments, and to curb prescription-related opioid misuse. In a press release, the FDA said that the cornerstone of the ...

An HHS spokesperson confirmed Prasad's reappointment as chief medical and scientific officer, one month after his surprising ...

On September 3, 2025, the Food and Drug Administration (FDA) announced its submission of a proposed information collection to ...